Current and emerging options in the treatment of onychomycosis

Area of Science:

• Dermatology
• Mycology
• Pharmacology

Background:

• Onychomycosis, a fungal nail infection, presents significant treatment challenges.
• Current therapeutic options include systemic antifungals, topical agents, and laser treatments.
• High recurrence rates necessitate ongoing research into effective and preventive strategies.

Purpose of the Study:

• To review the current landscape of onychomycosis treatments.
• To evaluate the efficacy and potential of emerging therapies.
• To highlight the importance of preventive measures in managing fungal nail infections.

Main Methods:

• Review of currently approved systemic antifungal agents (fluconazole, itraconazole, terbinafine).
• Analysis of available and investigational topical treatments (ciclopirox, efinaconazole, tavaborole).
• Consideration of adjunctive therapies like laser systems and mechanical modalities.

Main Results:

• Systemic and topical antifungals, alongside laser systems, are established treatment modalities.
• Newer topical agents like tavaborole demonstrate significant therapeutic potential.
• Mechanical interventions are generally supplementary rather than primary treatments.

Conclusions:

• While effective treatments exist, onychomycosis recurrence remains a clinical concern.
• Adherence to preventive strategies, including prompt treatment of tinea pedis, is crucial for long-term management.
• The development of novel topical agents offers improved options for patients suffering from fungal nail infections.